【古书解读】含利多卡因的瑞蓝临床研究—医生与求美者的福音

END

CN-RES- 2100065

材料仅供医疗卫生工作者求学交流

不作为外科运用于推荐及其他用途

关的外科应用应相悖国家药品监督管理局批准的运用于简要

pi/pi_restylane

供参考：

1. Data on file.

2. American Society of Plastic Surgeons. 2000/2007/2008 national plastic surgery statistics. Cosmetic and reconstructive procedure trends. Arlington Heights (IL): American Society of Plastic Surgeons; 2009. Available at: stats/2008-cosmetic-reconstructive-plastic-surgery-minimallyinvasive-statistics.pdf Accessed August 26, 2009.

3. Olenius M. The first clinical study using a new biodegradable implant for the treatment of lips, wrinkles, and folds. Aesth Plast Surg 1998;22:97–101.

4. Narins RS, Brandt F, Leyden J, et al. Randomized, double-blind, multi-center comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg 2003;19:588–95.

5. Restylanes Product Information. Medicis Aesthetics, Inc. December 2008 Available at: pi/pi_restylane.pdf Accessed August 31, 2009.

6. Matarasso SL, Carruthers JD, Jewell MLRestylane Consensus Group. Consensus recommendations for soft-tissue augmentation with nonanimal stabilized hyaluronic acid (Restylane). Plast Reconstr Surg 2006;117(3 Suppl):3S–34S.

7. Weiss R , Bank D , Brandt F . Randomized, Double-Blind, Split-Face Study of Small-Gel-Particle Hyaluronic Acid with and without Lidocaine During Correction of Nasolabial Folds[J]. Dermatologic Surgery, 2010.